Elanco Animal Health Gross Margin 2016-2026 | ELAN
Current and historical gross margin for Elanco Animal Health (ELAN) over the last 10 years. The current gross profit margin for Elanco Animal Health as of June 30, 2026 is %.
| Elanco Animal Health Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-06-30 | $5.02B | $2.78B | 55.36% |
| 2026-03-31 | $4.89B | $2.69B | 55.06% |
| 2025-12-31 | $4.72B | $2.59B | 54.99% |
| 2025-09-30 | $4.59B | $2.52B | 54.96% |
| 2025-06-30 | $4.48B | $2.45B | 54.73% |
| 2025-03-31 | $4.43B | $2.43B | 54.89% |
| 2024-12-31 | $4.44B | $2.44B | 54.88% |
| 2024-09-30 | $4.45B | $2.44B | 54.69% |
| 2024-06-30 | $4.49B | $2.48B | 55.19% |
| 2024-03-31 | $4.37B | $2.41B | 55.28% |
| 2023-12-31 | $4.42B | $2.49B | 56.28% |
| 2023-09-30 | $4.37B | $2.50B | 57.33% |
| 2023-06-30 | $4.32B | $2.48B | 57.26% |
| 2023-03-31 | $4.44B | $2.54B | 57.27% |
| 2022-12-31 | $4.41B | $2.50B | 56.63% |
| 2022-09-30 | $4.54B | $2.56B | 56.49% |
| 2022-06-30 | $4.64B | $2.64B | 56.83% |
| 2022-03-31 | $4.75B | $2.68B | 56.36% |
| 2021-12-31 | $4.76B | $2.63B | 55.25% |
| 2021-09-30 | $4.79B | $2.57B | 53.69% |
| 2021-06-30 | $4.55B | $2.39B | 52.55% |
| 2021-03-31 | $3.86B | $1.95B | 50.64% |
| 2020-12-31 | $3.27B | $1.60B | 49.04% |
| 2020-09-30 | $2.92B | $1.44B | 49.30% |
| 2020-06-30 | $2.80B | $1.40B | 50.07% |
| 2020-03-31 | $3.00B | $1.54B | 51.33% |
| 2019-12-31 | $3.07B | $1.60B | 52.13% |
| 2019-09-30 | $3.08B | $1.61B | 52.25% |
| 2019-06-30 | $3.07B | $1.59B | 51.77% |
| 2019-03-31 | $3.06B | $1.50B | 49.13% |
| 2018-12-31 | $3.07B | $1.49B | 48.70% |
| 2018-06-30 | $2.20B | $1.04B | 47.03% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $11.421B | $4.715B |
| Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.874B | 13.39 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.368B | 15.15 |
| Encompass Health (EHC) | United States | $12.224B | 21.22 |
| Chemed (CHE) | United States | $6.665B | 23.76 |
| RadNet (RDNT) | United States | $5.964B | 172.23 |
| LifeStance Health (LFST) | United States | $4.888B | 98.39 |
| Option Care Health (OPCH) | United States | $3.665B | 15.49 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.112B | 21.61 |
| Addus HomeCare (ADUS) | United States | $2.213B | 20.02 |
| Astrana Health (ASTH) | United States | $2.101B | 22.31 |
| Pennant (PNTG) | United States | $1.484B | 38.62 |
| U.S Physical Therapy (USPH) | United States | $1.244B | 32.83 |
| Daxor (DXR) | United States | $0.068B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.022B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |